Proton

The Prime objective of “Proton Pump Inhibitors Market” report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 to 2024. In order to present an executive-level model of the market and its future perspectives, the report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.

Request For Sample Copy of Proton Pump Inhibitors Market Report @ https://www.industryresearch.co/enquiry/request-sample/13999751

Top Key Players Are:

  • AstraZeneca
  • Bayer AG
  • Cadila Pharmaceuticals
  • Eli Lilly and Company
  • Eisai Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Santarus Inc.
  • Takeda Pharmaceuticals

    Proton Pump Inhibitors Market Report Covers the Top Regions:

    United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, GCC, South Africa, Brazil, Argentina.

    Scope of Proton Pump Inhibitors Market:

    , proton pump inhibitors (PPIs) are a group of drugs, whose main action is the long-lasting reduction of gastric acid production. They are the most potent inhibitors of acid secretion available. The market studied is further segmented on the basis of drug type and geography. The drug type segmentation includes OTC and prescription drugs.

    Have Any Query, Ask Our Industry Experts @ https://www.industryresearch.co/enquiry/pre-order-enquiry/13999751

    Key Market Trends:

    Esomeprazole is Expected to Account for the Largest Market Share in Drug Type

    Nexium is one among the leading revenue generating drugs ly, and it is used to treat the symptoms of GERD, heartburn, and other disorders involving excessive stomach acids. The drug was being sold as a prescriptive drug till before 28th March 2014, the date when FDA approved it as an OTC drug. The shift from being a prescription-only drug to being sold as an over-the-counter (OTC) drug is likely to be a major driving force for the sales of the drug in the near future. There are several benefits associated with OTC drugs, such as low price, enhanced accessibility, and no regular monitoring. As OTC drugs are sold without any prescription, the consumer need not go to any doctor for a prescription, which reduces the overall cost, and hence these drugs have the potential to increase their adoption rate. Accessibility is another vital factor for the consumption of any medicine, and better accessibility may definitely result in more revenue. However, OTC drugs have some disadvantages as well. As they can be purchased without any prescription, anyone can buy as many as they want and leave the scope for their overuse.

    Additionally, there are several minor side effects, such as nausea, headaches, dry mouth, diarrhea, allergic reaction, and others, as well as some major side effects, such as kidney disease, dementia, and others associated with its use, which can affect the adoption rate, and hence can be the restraining factors for the growth of the market.

    North America Accounted for the Largest Share in the Market

    North America holds a major share in the proton pump inhibitors market and is expected to show a similar trend over the forecast period, without significant fluctuations. There is a rising prevalence of GERD in the United States, Canada, and Mexico. Furthermore, GERD affects up to 20% of adults in the United States, therefore making the disease an important concern. Proton pump inhibitors are the widely prescribed drugs, and increased PPI use has been observed in the US ambulatory settings. Furthermore, many firms are expected to spend heavily on promoting their brands. The widespread use of these has recently gained attention from the American Board of Internal Medicine’s campaign to promote the appropriate use of PPIs.

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Purchase Proton Pump Inhibitors Market Report @ https://www.industryresearch.co/purchase/13999751

    Price of Report: $ 4250 (SUL)

    Detailed TOC of Proton Pump Inhibitors Market Research Report 2019 – 2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Gastroesophageal Reflux Disease (GERD)
    4.2.2 Rising Acceptance of Novel Drug Delivery Systems
    4.3 Market Restraints
    4.3.1 Increasing Use of Generic Products
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug Type
    5.1.1 OTC (Over-the-Counter) Drugs
    5.1.1.1 Omeprazole
    5.1.1.2 Lansoprazole
    5.1.1.3 Esomeprazole
    5.1.1.4 Other OTC Drugs
    5.1.2 Prescription Drugs
    5.1.2.1 Rabeprazole
    5.1.2.2 Dexlansoprazole
    5.1.2.3 Pantoprazole
    5.1.2.4 Other Prescription Drugs
    5.2 Geography
    5.2.1 North America
    5.2.1.1 US
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 UK
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South Korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 AstraZeneca
    6.1.2 Bayer AG
    6.1.3 Cadila Pharmaceuticals
    6.1.4 Eli Lilly and Company
    6.1.5 Eisai Inc.
    6.1.6 GlaxoSmithKline PLC
    6.1.7 Johnson & Johnson
    6.1.8 Pfizer Inc.
    6.1.9 Santarus Inc.
    6.1.10 Takeda Pharmaceuticals

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Potassium Nitrate Market 2019 Global Share, Business Growth, Trend, Segmentation, Top Key Players Analysis Industry, Opportunities and Forecast to 2023

  • Charles Bevers
    News Reporter